BACKGROUND: Advanced cancer brings substantial physical and psychosocial challenges that may contribute to emotional distress and diminish well-being. In this study, we present preliminary data concerning the effectiveness of a new brief individual psychotherapy, Managing Cancer And Living Meaningfully (CALM), designed to help individuals cope with this circumstance. AIM: To test the feasibility and preliminary effectiveness of CALM to reduce emotional distress and promote psychological well-being and growth. DESIGN: CALM is a brief, manualized, semi-structured individual psychotherapy for patients with advanced cancer. This study employed a phase 2 intervention-only design. The primary outcome was depressive symptoms and the secondary outcomes were death anxiety, attachment security, spiritual well-being and psychological growth. These were assessed at 3 months (t1) and 6 months (t2). Multilevel regression was used to model change over time. SETTING/PARTICIPANTS: A total of 50 patients with advanced or metastatic cancer were recruited from the Princess Margaret Cancer Centre, Toronto, Canada. RESULTS: A total of 39 patients (78%) were assessed at baseline, 24 (48%) at t1, and 16 (32%) at t2. Analyses revealed reductions over time in depressive symptoms: beta = -0.13, confidence interval (CI.95) = (-0.23, -0.022) and death anxiety: beta = -0.23, CI.95 (-0.40, -0.061); and an increase in spiritual well-being: beta = 0.14, CI.95 (0.026, 0.26). CONCLUSIONS: CALM may be a feasible intervention to benefit patients with advanced cancer. The results are encouraging, despite attrition and small effect sizes, and support further study.
BACKGROUND: Advanced cancer brings substantial physical and psychosocial challenges that may contribute to emotional distress and diminish well-being. In this study, we present preliminary data concerning the effectiveness of a new brief individual psychotherapy, Managing Cancer And Living Meaningfully (CALM), designed to help individuals cope with this circumstance. AIM: To test the feasibility and preliminary effectiveness of CALM to reduce emotional distress and promote psychological well-being and growth. DESIGN: CALM is a brief, manualized, semi-structured individual psychotherapy for patients with advanced cancer. This study employed a phase 2 intervention-only design. The primary outcome was depressive symptoms and the secondary outcomes were death anxiety, attachment security, spiritual well-being and psychological growth. These were assessed at 3 months (t1) and 6 months (t2). Multilevel regression was used to model change over time. SETTING/PARTICIPANTS: A total of 50 patients with advanced or metastatic cancer were recruited from the Princess Margaret Cancer Centre, Toronto, Canada. RESULTS: A total of 39 patients (78%) were assessed at baseline, 24 (48%) at t1, and 16 (32%) at t2. Analyses revealed reductions over time in depressive symptoms: beta = -0.13, confidence interval (CI.95) = (-0.23, -0.022) and death anxiety: beta = -0.23, CI.95 (-0.40, -0.061); and an increase in spiritual well-being: beta = 0.14, CI.95 (0.026, 0.26). CONCLUSIONS: CALM may be a feasible intervention to benefit patients with advanced cancer. The results are encouraging, despite attrition and small effect sizes, and support further study.
Entities:
Keywords:
Affective symptoms; cancer; death anxiety; depression; palliative care; pilot trial; psychotherapy
Authors: Barry Rosenfeld; Rebecca Saracino; Kristen Tobias; Melissa Masterson; Hayley Pessin; Allison Applebaum; Robert Brescia; William Breitbart Journal: Palliat Med Date: 2016-07-21 Impact factor: 4.762
Authors: Katherine M Piderman; Simon Kung; Sarah M Jenkins; Terin T Euerle; Timothy J Yoder; Gracia M Kwete; Maria I Lapid Journal: Curr Oncol Rep Date: 2015-02 Impact factor: 5.075
Authors: Katherine M Piderman; Terin T Sytsma; Marlene H Frost; Paul J Novotny; Sarah M Rausch Osian; Lise Solberg Nes; Christi A Patten; Jeff A Sloan; Teresa A Rummans; Carrie A Bronars; Ping Yang; Matthew M Clark Journal: J Pastoral Care Counsel Date: 2015-09
Authors: Ashlee R Loughan; Kelcie D Willis; Sarah Ellen Braun; Gary Rodin; Autumn Lanoye; Alexandria E Davies; Dace Svikis; Suzanne Mazzeo; Mark Malkin; Leroy Thacker Journal: J Neurooncol Date: 2022-04-18 Impact factor: 4.506
Authors: William Breitbart; Hayley Pessin; Barry Rosenfeld; Allison J Applebaum; Wendy G Lichtenthal; Yuelin Li; Rebecca M Saracino; Allison M Marziliano; Melissa Masterson; Kristen Tobias; Natalie Fenn Journal: Cancer Date: 2018-05-14 Impact factor: 6.860
Authors: Lisa M Gudenkauf; Matthew M Clark; Paul J Novotny; Katherine M Piderman; Shawna L Ehlers; Christi A Patten; Lise Solberg Nes; Kathryn J Ruddy; Jeff A Sloan; Ping Yang Journal: Clin Lung Cancer Date: 2019-06-19 Impact factor: 4.785